CADBURY SCHWEPPES BUYS PFIZER CANDY UNIT

$4.2 Billion Cash Deal for Adams Nets Dentyne and Trident

By Published on .

NEW YORK (AdAge.com) -- Cadbury Schweppes earlier today said it agreed to buy Pfizer's confectionary division, Adams, for $4.2 billion in cash.

The purchase of the unit, which pharmaceutical giant Pfizer put on the block in June, will give British-based Cadbury Schweppes equal footing with confectionery rival Nestle and make it No. 2 to Wm. Wrigley Jr. Co. in chewing gum.

Chocolate and soft drinks
Cadbury executives also said

Related Stories:
PFIZER LOOKS TO SELL OFF NON-DRUG BRANDS
Adams Confectionery, Schick-Wilkinson Being Shopped
OFF THE SALES BLOCK, HERSHEY LOOKS AHEAD
Candy Marketer Plans to Improve Advertising, Launch New Products
PUBLICIS GETS $50 MILLION CADBURY CHOCOLATE ACCOUNT
Business Was With Soon-to-Close D'Arcy
the deal takes the company a step further into the functional confectionary sector through Adams' gum brands, which include Trident and Dentyne, Halls cough drops, Clorets breath fresheners and Certs mints. Along with Cadbury chocolate, the company also controls the soft drink brands Dr Pepper and 7 Up.

In September, Cadbury tried to buy Hershey Foods in a $10.5 billion joint offer with Nestle. The Hershey Trust Co., which controls Hershey foods, ultimately ended its quest to sell the company.

On the block
Pfizer, meanwhile, has been looking to sell the non-core businesses it had acquired in its merger with Warner-Lambert Co. Remaining to be sold are the Schick-Wilkinson Sword shaving products that are marketed under the Schick brand.

In this article:
Most Popular